|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A complete sequence and comparative analysis of a SARS-associated virus(Isolate BJ01)显示文摘The genome sequence of the Severe Acute Respiratory Syndrome (SARS)-associated virus provides essential information for the identification of pathogen(s), exploration of etiology and evolution, interpretation of transmission and pathogenesis, development of diagnostics, prevention by future vaccination, and treatment by developing new drugs. We report the complete genome sequence and comparative analysis of an isolate (BJ01) of the coronavirus that has been recognized as a pathogen for SARS. The genome is 29725 nt in size and has 11 ORFs (Open Reading Frames). It is composed of a stable region encoding an RNA-dependent RNA polymerase (composed of 2 ORFs) and a variable region representing 4 CDSs (coding sequences) for viral structural genes (the S, E, M, N proteins) and 5 PUPs (putative uncharacterized proteins). Its gene order is identical to that of other known coronaviruses. The sequence alignment with all known RNA viruses places this virus as a member in the family of Coronaviridae. Thirty putative substitutions have been identified by comparative analysis of the 5 SARS- associated virus genome sequences in GenBank. Fifteen of them lead to possible amino acid changes (non-synonymous mutations) in the proteins. Three amino acid changes, with predicted alteration of physical and chemical features, have been detected in the S protein that is postulated to beinvolved in the immunoreactions between the virus and its host. Two amino acid changes have been detected in the Mprotein, which could be related to viral envelope formation. Phylogenetic analysis suggests the possibility of non-human origin of the SARS-associated viruses but provides noevidence that they are man-made. Further efforts should focus on identifying the etiology of the SARS-associated virus and ruling out conclusively the existence of otherpossible SARS-related pathogen(s). | QIN E'de ZHU Qingyu YU Man FAN Baochang CHANG Guohui SI Bingyin YANG Bao PENG Wenming JIANG Tao LIU Bohua DENG Yongqiang LIU Hong ZHANG Yu WANG Cui LI Yuquan GAN Yonghua LI Xiaoyu L Fushuang TAN Gang CAO Wuchun, YANG Ruifu Institute of Microbiology and Epidemiology, Chinese Academy of Military Medical Sciences, Beijing 100071, China WANG Jian, LI Wei, XU Zuyuan, LI Yan, WU Qingfa, LIN Wei, CHEN Weijun, TANG Lin, DENG Yajun, HAN Yujun, LI Changfeng, LEI Meng, LI Guoqing, LI Wenjie, L Hong, SHI Jianping, TONG Zongzhong, ZHANG Feng, LI Songgang, LIU Bin, LIU Siqi, DONG Wei, WANG Jun, Gane K-S Wong, YU Jun & YANG Huanming* Beijing Genomics Institute, Chinese Academy of Sciences, Beijing 101300 National Center for Genome Information, Beijing 101300, China | 2003 | Chinese Science Bulletin2003，48，10： | 121 |
| 2 | 东沙群岛海区晚新生代构造特征及其对弧-陆碰撞的响应显示文摘东沙群岛及其邻近海区 (简称东沙海区 )位于南海北部大陆边缘 ,东邻马尼拉俯冲构造带。为了讨论晚新生代以来东沙海区的构造变形特征 ,从中找出吕宋弧对中国东南大陆边缘碰撞的构造相关 ,特别是 8Ma以来的吕宋岛弧和中国大陆边缘之间构造消减过程的响应。根据地震地层学分析 ,结合区域重磁资料、ODP1 84钻孔资料对东沙群岛海区晚新生代构造特征进行了分析。东沙海区自南海扩张后发育了 3个沉积层序 (层序Ⅴ ,Ⅵ ,Ⅶ ) ,经历了较强烈的构造抬升作用、岩浆活动、沉积物剥蚀。该区发育NEE SWW和NW SE向两组断裂 ,且以NEE SWW向断裂最为发育。断裂大多具有多次活动 ,且为上新世到第四纪的活动断裂构造 ,断块抬升幅度大 ,沿断裂带发生岩浆侵入。分析结果表明 ,晚新生代期间经历了二次重要的构造运动 ,即东沙运动 ( 9 8— 4 4Ma)和流花运动 ( 1 89— 1 4Ma) ,奠定了该区的构造格局。综合该区东强西弱构造变形、构造抬升发生的时间和应力场变化等特征看 ,该区受 8Ma以来中国东部大陆边缘与吕宋岛弧碰撞所产生的构造运动的影响 ,在 8Ma以前 ,由于台湾岛不存在 ,活动的古东海大陆边缘延伸至东沙群岛海区东北部。 | 吴时国 刘展 王万银 郭军华 Lüdmann T Wong H K | 2004 | 海洋与湖沼2004，35，6： | 29 |
| 3 | Role of LPS/CD14/TLR4-mediated inflammation in necrotizing enterocolitis:Pathogenesis and therapeutic implications显示文摘AIM:To establish the roles of lipopolysaccharide (LPS)/CD14/toll-like receptor 4 (TLR4)-mediated inflammation in a rat model of human necrotizing enterocolitis (NEC).METHODS: Six pairs of intestinal samples from human NEC were collected before and after recovery for histological and molecular analysis of inflammatory cytokines and signaling components. In the rat NEC model, we isolated 10-cm jejunum segments and divided them into six groups (n=6) for sham operation, treatment with LPS, bowel distension, combined bowel distension and LPS stimulation, and two therapeutic groups. The potential eff icacy of a recombinant CD18 peptide and a monoclonal CD14 antibody was evaluated in the latter two groups. The serum and tissue levels of several inflammatory mediators were quantified by real-time polymerase chain reaction, ELISA and immunoblotting.RESULTS: Human acute phase NEC tissues displayed significant increases (P<0.05) in levels of TLR4, CD14, myeloid differentiation protein (MD)-2, tumor necrosis factor (TNF)-α and nuclear factor-κB when compared to those after recovery. The histological and inflammatory picture of human NEC was reproduced in rats that were treated with combined bowel distension and LPS, but not in the sham-operated and other control rats. Serum levels of interleukin-6 and TNF-α were also elevated. The NEC pathology was attenuated by treating the NEC rats with a monoclonal CD14 antibody or an LPS-neutralizing peptide.CONCLUSION:LPS and distension are required to produce the histological and inflammatory features of NEC. A potential treatment option is blocking LPS activation and leukocyte infi ltration. | Kwong L Chan Kwong F Wong John M Luk | 2009 | World Journal of Gastroenterology2009，15，38： | 17 |
| 4 | 4.4 A Resolution Cryo-EM structure of human mTOR Complex 1显示文摘 | Huirong Yang Jia Wang Mengjie Liu Xizi Chen Min Huang Dan Tan Meng-Qiu Dong Catherine C. L, Wong Jiawei Wang Yanhui Xu Hong-Wei Wang | 2016 | Protein & Cell2016，7，12： | 7 |
| 5 | Therapeutic interventions for heart failure with preserved ejection fraction:A summary of current evidence显示文摘Heart failure with preserved ejection fraction(HFPEF)is common and represents a major challenge in cardiovascular medicine.Most of the current treatment of HFPEF is based on morbidity benefits and symptom reduction.Various pharmacological interventions available for heart failure with reduced ejection fraction have not been supported by clinical studies for HFPEF.Addressing the specific aetiology and aggressive risk factor modification remain the mainstay in the treatment of HFPEF.We present a brief overview of the currently recommended therapeutic options with available evidence. | Muhammad Asrar ul Haq Chiew Wong Vivek Mutha Nagesh Anavekar Kwang Lim Peter Barlis David L Hare | 2014 | World Journal of Cardiology2014，6，2： | 7 |
| 6 | 视网膜微血管异常与MRI确诊的亚临床脑梗死:动脉粥样硬化风险的社区研究显示文摘Background and Purpose-Retinal microvascular abnormalities reflect cumulative small vessel damage from elevated blood pressure and may reflect subclinical cerebral microvascular changes.We examined their associations with MRI-defined cerebral infarcts.Methods-Population-based,cross-sectional study of 1684 persons 55 to 74 years of age without a history of clinical stroke,sampled from 2 US southeastern communities.Retinal photographs were obtained and graded for presence of retinal microvascular abnormalities,including arteriovenous nicking,focal arteriolar narrowing,retinal hemorrhages,soft exudates and microaneurysms.Photographs were also digitized,and retinal vessel diameters were measured and summarized as the arteriole-to-venule ratio(AVR).Cerebral MRI scans were graded for presence of cerebral infarct,defined as a lesion ≥ 3 mm diameter in a vascular distribution with typical imaging characteristics.Results-There were a total of 183 MRI cerebral infarcts.After adjustment for age,gender,race,6-year mean arterial blood pressure,diabetes,and other stroke risk factors,cerebral infarcts were associated with retinal microvascular abnormalities,with odds ratios 1.90(95% CI,1.25 to 2.88)for arteriovenous nicking,1.89(95% CI,1.22 to 2.92)for focal arteriolar narrowing,2.95(95% CI,1.30 to 6.71)for blot hemorrhages,2.08(95% CI,0.69,6.31)for soft exudates,3.17(95% CI,1.05 to 9.64)-for microaneurysms,and 1.74(95% CI,0.95 to 3.21)for smallest compared with largest AVR.In stratified analyses,these associations were only present in persons with hypertension.Conclusions-Retinal microvascular abnormalities are associated with MRI-defined subclinical cerebral infarcts independent of stroke risk factors.These data suggest that retinal photography may be useful for studying subclinical cerebrovascular disease in population-based studies. | Cooper L S. Wong T. Y. Klein R. 王文军(译) | 2006 | 世界核心医学期刊文摘(眼科学分册)2006，2，9： | 6 |
| 7 | SPSBl-mediated HnRNP A1 alternative splicing and cell ubiquitylation regulates migration in EGF signaling显示文摘细胞外的信号被显示了影响拼接的其他的 pre-mRNA;然而,分子的机制和导致信号的拼接的规定的生物意义仍然保持大部分未知。这里,我们报导那个表皮的生长因素(EGF ) 通过一个著名拼接管理者的 ubiquitylation 导致拼接的变化, hnRNP A1。EGF 发信号 upregulates 一个 E3 ubiquitin (Ub ) ligase 适配器,敏捷的包含域的 SOCS 盒子蛋白质 1 (SPSB1 ) ,它结合离氨酸 29 连接 polyUb 链到 hnRNP A1 上的成员 Elongin B/C-Cullin 建筑群。重要地, hnRNP A1 的 SPSB1 和 ubiquitylation 在驾驶 EGF 的房间移植有一个关键角色。机械学地,和 SR 蛋白质 kinases (SRPK ) 的激活的 hnRNP A1 的导致 EGF 的 ubiquitylation 导致拼接的 Rac1 的 upregulation isoform, Rac1b,支持房间活动性。这些调查结果解开在蛋白质 ubiquitylation 并且在 EGF/EGF 受体发信号的其他的拼接之间的新奇串音,并且在 modulating 房间移植识别新 EGF/SPSB1/hnRNP A1/Rac1 轴,它可以为癌症治疗有重要含意。 | Feng Wang Xing Fu Peng Chen Ping Wu Xiaojuan Fan Na Li Hong Zhu Ting-Ting Jia Hongbin Ji Zefeng Wang Catherine C L Wong Ronggui Hu Jingyi Hui | 2017 | Cell Research2017，27，4： | 5 |
| 8 | Neoadjuvant treatment for resectable pancreatic adenocarcinoma显示文摘Pancreatic adenocarcinoma is the fourth leading cause of cancer mortality in the United States in both men and women, with a 5-year survival rate of less than 5%. Surgical resection remains the only curative treatment, but most patients develop systemic recurrence within 2 years of surgery. Adjuvant treatment with chemotherapy or chemoradiotherapy has been shown to improve overall survival, but the delivery of treatment remains problematic with up to 50% of patients not receiving postoperative treatment. Neoadjuvant therapy can provide benefits of eradication of micrometastasis and improved delivery of intended treatment. We have reviewed the findings from completed neoadjuvant clinical trials, and discussed the ongoing studies. Combinational cytotoxic chemotherapy such as fluorouracil, leucovorin, irinotecan, and oxaliplatin and gemcitabine plus nanoparticle albumin-bound(nab)-paclitaxel, active in the metastatic setting, are being studied in the neoadjuvant setting. In addition, novel targeted agents such as inhibitor of immune checkpoint are incorporated with cytotoxic chemotherapy in early-phase clinical trial. Furthermore we have explored the utility of biomarkers which can personalize treatment and select patients for target-driven therapy to improve treatment outcome. The treatment of resectable pancreatic adenocarcinoma requires multidisciplinary approach and novel strategies including innovative trials to make progress. | John Wong Naveenraj L Solomon Chung-Tsen Hsueh | 2016 | World Journal of Clinical Oncology2016，7，1： | 3 |
| 9 | 新加坡成人慢性呼吸系统疾病患者6分钟步行距离的最小临床重要差异值研究(英文)显示文摘目的:6 min步行距离(6MWD)是临床上常见的功能性运动能力测试,特别是对于慢性呼吸系统疾病患者。一些文献记载了关于白种人的6MWD的最小临床重要差异(MCID),但对亚洲人群的相关信息未见记载。本研究旨在建立亚洲成人慢性呼吸道疾病患者6MWD的最小临床重要差异。方法:采用'锚定'法和'分布'法对新加坡中央医院肺康复计划登记处的资料进行了分析。'锚定'法收集确诊为慢性呼吸道疾病的患者50例,其中男38例,女12例;平均年龄(64.2±12.3)岁,通过电话采访及使用整体变化评估量表(GROC)评价患者肺康复计划后的自觉改善程度,再将患者在肺康复计划中6MWD的改变数值与相对应的患者自觉改善程度进行比较,这种关系用操作特征曲线(ROC)统计表示。通过'分布'法确定6MWD的MCID,从门诊和住院的肺康复计划(PRP)参与者中检索医疗记录136例,其中男103例,女33例;平均年龄(60.1±14.1)岁。结果 :ROC曲线表明6MWD出现临床显著性变化的最佳临界值为17.4 m,其对应的敏感性为79.4%,特异性为81.3%,阳性似然比为4.23。由'分布'法确定6MWD的最小临床重要差异值为18.6 m。结论:18.6 m为新加坡华人6MWD的最小临床重要差异的估计值。 | Meredith T L YEUNG Alan W P WONG Katherine S L HUANG Alice Y M JONES | 2015 | 康复学报2015，25，1： | 3 |
| 10 | Icteric flare of chronic hepatitis B in a 95-year old patient显示文摘A 95-year old gentleman developed fatal icteric flare of chronic hepatitis B despite lamivudine treatment. This article highlights the atypical presentations of chronic hepatitis B in elderly patient and the need to consider this possibility for acute fulminant hepatitis in endemic areas. | WS Wong Wai Keung Leung Henry L Y Chan | 2003 | World Journal of Gastroenterology2003，9，12： | 3 |
| 11 | Endocrine radionuclide scintigraphy with fusion single photon emission computed tomography/computed tomography显示文摘AIM: To review the benefits of single photon emission computed tomography(SPECT)/computed tomography(CT) hybrid imaging for diagnosis of various endocrine disorders.METHODS: We performed MEDLINE and Pub Med searches using the terms: 'SPECT/CT'; 'functional anatomic mapping'; 'transmission emission tomography'; 'parathyroid adenoma'; 'thyroid cancer'; 'neuroendocrine tumor'; 'adrenal'; 'pheochromocytoma'; 'paraganglioma'; in order to identify relevant articles published in English during the years 2003 to 2015. Reference lists from the articles were reviewed to identify additional pertinent articles. Retrieved manuscripts(case reports, reviews, meta-analyses and abstracts) concerning the application of SPECT/CT to endocrine imaging were analyzed to provide a descriptive synthesis of the utility of this technology.RESULTS: The emergence of hybrid SPECT/CT camera technology now allows simultaneous acquisition of combined multi-modality imaging, with seamless fusion of three-dimensional volume datasets. The usefulness of combining functional information to depict the biodistribution of radiotracers that map cellular processes of the endocrine system and tumors of endocrine origin, with anatomy derived from CT, has improved the diagnostic capability of scintigraphy for a range of disorders of endocrine gland function. The literature describes benefits of SPECT/CT for ^(99m)Tc-sestamibi parathyroid scintigraphy and ^(99m)Tc-pertechnetate thyroid scintigraphy, ^(123)I- or ^(131)I-radioiodine for staging of differentiated thyroid carcinoma, ^(111)In- and ^(99m)Tclabeled somatostatin receptor analogues for detection of neuroendocrine tumors, ^(131)I-norcholesterol(NP-59) scans for assessment of adrenal cortical hyperfunction, and ^(123)I- or ^(131)I-metaiodobenzylguanidine imaging for evaluation of pheochromocytoma and paraganglioma.CONCLUSION: SPECT/CT exploits the synergism between the functional information from radiopharmaceutical imaging and anatomy from CT, translating to improved diagnostic accuracy and meaningful impact on patient care. | Ka-Kit Wong Arpit Gandhi Benjamin L Viglianti Lorraine M Fig Domenico Rubello Milton D Gross | 2016 | World Journal of Radiology2016，8，6： | 3 |
| 12 | The impact of improved auditor independence on audit market concentration in China显示文摘 | Mark L DeFond T.J Wong Shuhua Li | 2000 | Journal of Accounting and Economics2000，，3： | 3 |
| 13 | Ammonia stripping as a pretreatment for landfill leachate显示文摘 | Cheung K C Chu L M Wong M H | 1997 | Water Air and Soil Pollution1997，94，： | 2 |
| 14 | Preparation and development of equine hyperimmune globulin F(ab')_2 against severe acute respiratory syndrome coronavirus显示文摘Aim:The resurgence of severe acute respiratory syndrome(SARS)is still a threatbecause the causative agent remaining in animal reservoirs is not fully understood,and sporadic cases continue to be reported.Developing high titers of anti-SARShyperimmune globulin to provide an alternative pathway for emergent future pre-vention and treatment of SARS.Methods:SARS coronavims(CoV)F69(AY313906)and Z2-Y3(AY394989)were isolated and identified from 2 different Cantoneseonset SARS patients.Immunogen was prepared from SARS-CoV F69 strain.Sixhealth horses were immunized 4 times and serum was collected periodically tomeasure the profile of specific IgG and neutralizing antibodies using indirect en-zyme-linked immunosorbent assay and a microneutralization test.Sera were col-lected in large amounts at the peak,where IgG was precipitated using ammoniumsulphate and subsequently digested with pepsin.The product was then purifiedusing anion-exchange chromatography to obtain F(ab′)2 fragments,Results:Thespecific IgG and neutralizing antibody titers peaked at approximately week 7 afterthe first immunization,with a maximum value of 1:14210.The sera collected at thepeak were then purified.Fragment of approximately 15 g F(ab′)2 was obtained from1 litre antiserum and the purity was above 90% with the titer of 1:5120,which couldneutralize the other strain(SARS-CoV Z2-Y3)as well.Conclusion:This researchprovides a viable strategy for the prevention and treatment of SARS coronavirusinfection with equine hyperimmune globulin,with the purpose of combating anyresurgence of SARS. | Jia-hai LU Zhong-min GUO Wen-yu HAS Guo-ling WAN Ding-mei ZHANG Yi- fei WANG Sheng-yun SUN Qin-he YANG Huan-ying ZHENG Bing L WONG Nan-shan ZHONG | 2005 | Acta Pharmacologica Sinica2005，26，12： | 2 |
| 15 | Removal of heavy metals from anaerobically digested sewage sludge by isolated indigenous iron-oxidizing bacteria显示文摘 | L Xiang L.C Chan J.W.C Wong | 2000 | Chemosphere2000，，1： | 2 |
| 16 | Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis显示文摘 | M. Tadrous L. Wong M. M. Mamdani D. N. Juurlink M. D. Krahn L. E. Lévesque S. M. Cadarette | 2014 | Osteoporosis International2014，，4： | 2 |
| 17 | Facial trauma and ocular/orbital injury显示文摘 | Larian B Wong B Crumley R L | 1999 | J Craniomaxillofac Trauma1999，5，4： | 2 |
| 18 | A metaanalysis of laparoscopic cholecystectomy in patients with cirrhosis显示文摘 | Alessandra Puggioni Linda L Wong | 2003 | Journal of the American College of Surgeons2003，，6： | 2 |
| 19 | Evaluation of a 2D diode array for IMRT quality assurance显示文摘 | Daniel Létourneau Misbah Gulam Di Yan Mark Oldham John W. Wong | 2003 | Radiotherapy and Oncology2003，，2： | 2 |
| 20 | Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing显示文摘 | Chan K C Allen Jiang Peiyong Zheng Yama W L Liao Gary J W Sun Hao Wong John Siu Shing Shun N Chan Wing C Chan Stephen L Chan Anthony T C Lai Paul B S Chiu Rossa W K Lo Y M D | 2013 | Clinical Chemistry2013，，1： | 2 |
您所在的机构暂未开通此部分的功能，请联系管理员